Evaluation of the Sentinel Node Biopsy in Colorectal Carcinoma Including the Results of Immunohistochemical Examinations

References

• Chaber A., Krasnodebski I. W. Leczenie chirurgiczne nowotworów jelita grubego. In: Fraczek M. (eds.). Chirurgia nowotworów. Bielsko-Biala: a-medica press, 2003: 287307.
   Google Scholar
• Deans G. T., Parks T. G., Rowlands B. J., Spence R. A. J. Prognostic factors in colorectal cancer. Br J Surg, 1992, 79: 60813.
   Google Scholar
• Swanson R. S., Compton e. e., Stewart A. K., Bland K. I. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol, 2003, 10: 65–71.
   Google Scholar
• Saha S., Dan A., Beutler T. et al. Sentinel lymph node mapping technique in colon cancer. Sem Oncol, 2004, 31: 374–81.
   Google Scholar
• Murawa D., Szymaniak M., Burchardt W., Murawa P. Technical details of intraoperative sentinel lymph node mapping in colorec-tal cancer. Gastroenterol Pol, 2002, 9: 221–4.
   Google Scholar
• Moertel e. G., Fleming T. R., Macdonald J. S. et al. Levamisol and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med, 1990, 322: 352–8.
   Google Scholar
• International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators. Efficacy of adjuvant fluorouracil and folinic acid in colon cancer. Lancet, 1995, 345: 939–44.
   Google Scholar
• Saha S., Wiese D., Badin J. et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol, 2000, 7: 120–4.
   Google Scholar
• Cserni G., Vajda K., Tarjan M., Bori R., Svebis M., Baltas B. Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging ? Pathol Oncol Res, 1999, 5: 291–6.
   Google Scholar
• Wong J. H., Steineman S., Calderia e., Bowles J., Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg, 2001, 233: 515–21.
   Google Scholar
• Bilchik A. J., Nora D., Tollenaar R. A. et al. Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer, 2002, 38: 977–85.
   Google Scholar
• Kitagawa Y., Watanabe M., Hasegawa H. et al. Sentinel node mapping for colorectal cancer with radioactive tracer. Dis Colon Rectum, 2002, 45: 1476–80.
   Google Scholar
• Braat A., Oosterhuis J., Moll F. et al. Successful sentinel node identification in colon carcinoma using Patent Blue V. Eur J Surg Oncol, 2004, 30: 633–7.
   Google Scholar
• Murawa D., Spychala A., Kruba R., Murawa P. Significance of sentinel node biopsy and his histopathological evaluation in colorectal cancer — preliminary report. Pol Przeg Chir, 2005, 12: 1243–51.
   Google Scholar
• Joosten J. J., Strobbe L. J., Wauters e. A., Pruszczynski M., Wobbes T., Ruers T. J. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg, 1999, 86: 482–6.
   Google Scholar
• Merrie A. E., van Rij A. M., Phillips L. V., Rossaak J. I., Yun K., McCall J. L. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum, 2001, 44: 410–7.
   Google Scholar
• Bertagnolli M., Miedema B., Redston M. et al. Sentinel node staging of resectable colon cancer. Ann Surg, 2004, 240: 624–30.
   Google Scholar
• Bertoglio S., Sandrucci S., Percivale P. et al. Prognostic value of sentinel lymph node biopsy in the pathologic staging of colorectal cancer patients. J Surg Oncol, 2004, 85: 166–70.
   Google Scholar
• Greenson J. K., Isenhart e. E., RiceR., Mojzisik e., Houchens D., Martin E. W. Identification of occult micrometastases in pericolic lymp nodes of Duke’s B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer, 1994, 73: 563–9.
   Google Scholar
• Tschmelitsch J., Klimstra D. S., Cohen A. M. Lymph node micrometastases do not predict relapse in stage ii colon cancer. Ann Surg Oncol, 2000, 7: 601–8.
   Google Scholar